title: [Potential for the clinical use of intranasal rifathyroin for diagnosis and treatment].
abstract: It has been shown that stimulated TSH and prolactin levels in intranasal administration of rifathyroin are comparable with the results of i.v. administration of the drug. Intranasal administration can be used for both therapeutic and diagnostic purposes.
authors.forename: N T
authors.initials: NT
authors.lastname: Starkova
authors.forename: S A
authors.initials: SA
authors.lastname: Butrova
authors.forename: S I
authors.initials: SI
authors.lastname: Surkov
authors.forename: G A
authors.initials: GA
authors.lastname: Kotova
authors.forename: A N
authors.initials: AN
authors.lastname: Nazarov
authors.forename: T A
authors.initials: TA
authors.lastname: Bobrovskaia
mesh_terms: D000281:Administration, Intranasal; D006042:Goiter / Q000188:drug therapy; D006801:Humans; D007037:Hypothyroidism / Q000188:drug therapy; D007275:Injections, Intravenous; D011388:Prolactin / Q000378:metabolism; D013972:Thyrotropin / Q000378:metabolism; D013973:Thyrotropin-Releasing Hormone / Q000627:therapeutic use*
chemical_list: D013973:Thyrotropin-Releasing Hormone; D011388:Prolactin; D013972:Thyrotropin
vernacular_title: O vozmozhnosti klinicheskogo ispol'zovaniia intranazal'nogo vvedeniia rifatiroina dlia diagnostiki i lecheniia.